ACCENDRA HEALTH INC/VA/ Gross Profit

• ACCENDRA HEALTH INC/VA/ showed an increase of +4.4% in Gross Profit from 2023 to 2024.
• This data is from ACCENDRA HEALTH INC/VA/'s annual report (Form 10-K), filed with the SEC on February 28, 2025.
• XBRL data for this metric is available from 2008 to 2024 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q2 2009: $197.70 million | Q3 2009: $204.34 million | Q1 2010: $197.00 million | Q2 2010: $198.94 million | Q3 2010: $203.95 million | Q1 2011: $210.78 million | Q2 2011: $216.07 million | Q3 2011: $216.68 million | Q1 2012: $214.33 million | Q2 2012: $211.43 million | Q3 2012: $228.12 million | Q1 2013: $279.05 million | Q2 2013: $273.43 million | Q3 2013: $273.33 million | Q1 2014: $281.20 million | Q2 2014: $282.27 million | Q3 2014: $292.48 million | Q1 2015: $297.60 million | Q2 2015: $298.34 million | Q3 2015: $306.35 million | Q1 2016: $296.64 million | Q2 2016: $299.42 million | Q3 2016: $296.28 million | Q1 2017: $281.18 million | Q2 2017: $273.53 million | Q3 2017: $301.94 million | Q1 2018: $324.69 million | Q2 2018: $324.99 million | Q3 2018: $352.57 million | Q1 2019: $276.62 million | Q2 2019: $286.52 million | Q3 2019: $280.62 million | Q1 2020: $268.56 million | Q2 2020: $269.41 million | Q3 2020: $344.34 million | Q1 2021: $442.75 million | Q2 2021: $400.07 million | Q3 2021: $328.84 million | Q1 2022: $373.45 million | Q2 2022: $532.51 million | Q3 2022: $513.28 million | Q1 2023: $497.31 million | Q2 2023: $519.43 million | Q3 2023: $538.50 million | Q1 2024: $535.53 million | Q2 2024: $544.15 million | Q3 2024: $559.71 million | Q1 2025: $526.01 million.
• Over the full 17 years of available data (2008 to 2024), ACCENDRA HEALTH INC/VA/'s Gross Profit has grown by 199.4%.
• Historical annual values: Fiscal year 2024: $2.22 billion | Fiscal year 2023: $2.13 billion | Fiscal year 2022: $1.83 billion | Fiscal year 2021: $1.51 billion | Fiscal year 2020: $1.28 billion | Fiscal year 2019: $1.13 billion | Fiscal year 2018: $1.07 billion | Fiscal year 2017: $1.17 billion | Fiscal year 2016: $1.19 billion | Fiscal year 2015: $1.21 billion | Fiscal year 2014: $1.17 billion | Fiscal year 2013: $1.12 billion | Fiscal year 2012: $924.65 million | Fiscal year 2011: $857.54 million | Fiscal year 2010: $807.73 million | Fiscal year 2009: $814.39 million | Fiscal year 2008: $741.11 million.
• Data sourced from SEC EDGAR public filings as of August 6, 2026.

Last verified: August 6, 2026